Safety Information
| Description | Publish Date | LINKS |
|---|---|---|
| Salbutamol pMDI, Advisory Letter | 12/08/2025 |  |
| Important safety information on Resorcinol in Togo | 23/02/2022 | |
| Important safety information on Cefuroxime sodium in Togo (Safety Notification_Cefuroxime Class 4 Defect MHRA) | 30-10-2023 | |
Important safety information on Amoxicillin/clavulanic acid containing products - MedSafe communication regarding labelling updates |
26/12/2023 |
|
Important safety information on Zanamivir containing products - Precautions for prescribing and administering flu medications (zanamivir) |
29/12/2023 |
|
Important safety information on Paroxetine containing products - Modifications of the information of medicines authorized by national procedure that contain Paroxetine |
28/12/2023 |
|
